KV Pharmaceutical Company (KV.A) - Adam Greene at Stanford Group

The difference between voluntary retirement and being fired may make a big monetary difference for Hermelin, who was credited with $8.66 million in total compensation last year. Adam Greene, an analyst at Stanford Group in New York, thinks KV's governance situation may remain messy for a while. "We do not expect this disagreement to go away quietly and (would) not be surprised if a legal dispute followed," he wrote in a research report this week. KV faces at least seven shareholder suits over the drop in its stock price, and a battle with its ex-CEO will add to its legal bills. If this goes to court, though, at least we may learn more about the boardroom intrigue that turned a retirement into a firing within a matter of hours.